Sign in
Explore the registryTrack Capivasertib's trials

CAPItrue

Capivasertib+Fulvestrant asTreatment for Locally Advanced(Inoperable) or Metastatic HR+/HER2- Breast Cancer in Chinese Patients

CapivasertibOngoingActive not recruitingPhase 3Open NCT06635447 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…